Skip to content
TrialScanner

NCT00081809

A Safety and Effectiveness Study of Vaccine Therapy in Patients With Indolent Lymphoma

Phase 2CompletedAGENLead

Registry record

Lead sponsor
Agenus Inc.
Conditions
Lymphoma, Follicular; Lymphoma, Small Lymphocytic
Primary completion
Jun 2005Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT00081809 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT00081809: A Safety and Effectiveness... | TrialScanner